Table 1.
Number and median age of vaccinees in the cohort who completed ≥1 questionnaire after the first and second dose.
| Number of vaccinees (%) | Median age (IQR) | ||||
|---|---|---|---|---|---|
| Males | Females | Total | Males | Females | |
| Dose 1 | |||||
| AstraZeneca | 1272 (14.5) | 7503 (85.5) | 8775 | 58 (41-64) | 48 (36-58) |
| Johnson&Johnson | 698 (28.4) | 1756 (71.6) | 2454 | 48 (36-54) | 45 (36-53) |
| Moderna | 1155 (33.7) | 2274 (66.3) | 3429 | 49 (41-55) | 45 (35-52) |
| Pfizer | 7486 (58.1) | 5396 (41.9) | 12,882 | 78 (74-81) | 71 (41-78) |
| Total | 10,611 (38.5) | 16,929 (61.5) | 27,540 | 74 (53-79) | 50 (37-62) |
| Dose 2 | |||||
| AstraZeneca | 836 (15.1) | 4707 (84.9) | 5543 | ||
| Johnson&Johnson | |||||
| Moderna | 881 (33.9) | 1718 (66.1) | 2599 | ||
| Pfizer | 6601 (60.4) | 4333 (39.6) | 10,934 | ||
| Total | 8318 (43.6) | 10,758 (56.4) | 19,076 | ||
IQR, interquartile range.